SCHEDULE 13D/A Filed 2026-05-14 Event 2026-05-12 SEC 0001104659-26-061506 →

Redmile Group, LLC → Atara Biotherapeutics, Inc. ATRA

Stake: 9.90% Shares: 950,994 CUSIP: 046513206 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

20 filings by this filer

19 other filings in the data moat

Short Interest · settle 2026-04-30

DTC 6.10

306,093 shares short · -3.7% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $331K

Point72 Asset Mgmt

Other 13D/G Filings on Atara Biotherapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-05-11	SCHEDULE 13D/A	Panacea Innovation Ltd	—	1,318,894	view →

Other Filings by Redmile Group, LLC

Filed	Form	Issuer	Stake	Shares
2025-04-29	SCHEDULE	Absci Corp ABSI	6.50%	8,335,116	view →
2024-07-19	SC	Augmedix, Inc.	—	—	view →
2023-12-28	SC	FATE THERAPEUTICS INC FATE	—	—	view →
2023-06-21	SC	MedAvail Holdings, Inc.	—	—	view →
2023-06-13	SC	IGM Biosciences, Inc.	—	—	view →
2023-03-15	SC	MedAvail Holdings, Inc.	—	—	view →
2022-10-05	SC	IGM Biosciences, Inc.	—	—	view →
2022-07-06	SC	MedAvail Holdings, Inc.	—	—	view →
2022-01-14	SC	MedAvail Holdings, Inc.	—	—	view →
2021-11-29	SC	MedAvail Holdings, Inc.	—	—	view →
2021-03-01	SC	Augmedix, Inc.	—	—	view →
2021-01-12	SC	FATE THERAPEUTICS INC FATE	—	—	view →
2020-12-15	SC	IGM Biosciences, Inc.	—	—	view →
2020-09-10	SC	IGM Biosciences, Inc.	—	—	view →
2019-10-24	SC	ALDER BIOPHARMACEUTICALS INC	—	—	view →
2019-09-17	SC	ALDER BIOPHARMACEUTICALS INC	—	—	view →
2019-09-17	SC	FATE THERAPEUTICS INC FATE	—	—	view →
2019-03-06	SC	ALDER BIOPHARMACEUTICALS INC	—	—	view →
2018-04-26	SC	ALDER BIOPHARMACEUTICALS INC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →